What Insider Trading Actually Means (And Why It’s Legal)
Most people hear “insider trading” and think handcuffs. The reality is far more nuanced—and far more useful to investors who know what to look for.
Say “insider trading” at a dinner party and people picture a Wall Street banker in handcuffs being perp-walked on CNBC. It’s one of the most misunderstood concepts in finance. The truth? Insider trading happens every single day, and most of it is perfectly legal.
Corporate executives, board directors, and major shareholders buy and sell their company’s stock all the time. When they do it transparently—filing the right paperwork, following SEC rules—it’s not only legal, it’s one of the most powerful data signals available to everyday investors.
This guide breaks down exactly what insider trading is, what makes it legal versus illegal, how to read the filings, and why decades of academic research suggest you should be paying close attention.
Who Counts as an “Insider”?
Under Section 16 of the Securities Exchange Act of 1934, the SEC defines corporate insiders as three groups of people:
These individuals have privileged access to information about a company’s operations, finances, and strategy. Because of this access, the SEC requires them to publicly disclose their transactions in company securities. The goal isn’t to prevent them from trading—it’s to ensure the rest of us can see what they’re doing.
Legal vs. Illegal: The Actual Distinction
Here’s the part most people get wrong: insider trading itself is not a crime. It becomes illegal only when specific conditions are met.
Legal Insider Trading
- Insider buys/sells company stock through open market
- Transaction is reported on Form 4 within 2 business days
- Trade is not based on material nonpublic information (MNPI)
- May use a pre-arranged 10b5-1 trading plan
- Complies with blackout period restrictions
Illegal Insider Trading
- Trading based on material, nonpublic information
- Breaches fiduciary duty or duty of trust
- “Tipping” MNPI to others who then trade
- Trading ahead of merger announcements, earnings surprises, FDA decisions
- Failing to disclose required transactions
The legal framework rests on two key concepts:
Material Nonpublic Information (MNPI)is information that a reasonable investor would consider important when making an investment decision, and that hasn’t yet been disclosed to the public. Think: unreleased earnings, pending mergers, FDA drug approvals, or major contract wins. If an insider trades while possessing this kind of information, they cross the line.
Breach of Dutyis the second element. Under the “classical theory,” an insider who trades on MNPI violates their fiduciary duty to shareholders. Under the “misappropriation theory” (established in United States v. O’Hagan, 1997), even an outsider can be liable if they misappropriate confidential information in violation of a duty to the source.
Form 4: Your Window Into Insider Activity
The Form 4 filing is the single most important document for tracking insider trades. Whenever a Section 16 insider executes a transaction, they must file a Form 4 with the SEC within 2 business days. These filings are publicly available on the SEC’s EDGAR system—and they’re what platforms like MarketPeel monitor in real time.
Transaction Codes That Matter
Not all insider transactions are created equal. The transaction code on a Form 4 tells you what kindof trade happened—and this makes a huge difference in how you should interpret it.
| Code | Meaning | What It Tells You | Signal |
|---|---|---|---|
| P | Open market purchase | Insider used personal cash to buy shares at market price. The strongest bullish signal. | High |
| S | Open market sale | Insider sold shares on the open market. Context matters—could be diversification, taxes, or genuine concern. | Context |
| M | Option exercise | Insider exercised stock options. Routine compensation event, not necessarily a sentiment signal. | Low |
| A | Grant or award | Company granted shares as compensation. No purchase decision by the insider. | Low |
| X | In-the-money exercise | Exercise of profitable derivative. Often immediately followed by a sale. | Low |
| G | Gift | Insider gifted shares. Estate planning, charity, or personal transfer. No sentiment signal. | Low |
10b5-1 Plans: Pre-Planned Trading
You’ll often see insider sales disclosed as part of a Rule 10b5-1 trading plan. These are pre-arranged schedules that insiders set up in advance—when they’re notin possession of material nonpublic information—to automatically buy or sell shares at predetermined times, prices, or quantities.
The idea is simple: an insider adopts a plan during a “clean” window, and then the plan executes automatically, providing an affirmative defense against insider trading allegations even if they later come into possession of MNPI.
Recent Tightening: The 2022–2023 Amendments
In December 2022, the SEC adopted major amendments to Rule 10b5-1 after years of criticism that insiders were gaming the system. Key changes:
Officers and directors must now wait the later of 90 days or 2 business days after disclosing financial results for the quarter in which the plan was adopted. Maximum: 120 days. Other insiders must wait 30 days.
Insiders can no longer maintain multiple active 10b5-1 plans for the same class of securities at the same time.
Directors and officers must certify in writing that they are not aware of MNPI and are adopting the plan in good faith.
Companies must now disclose in proxy statements when directors and officers have 10b5-1 plans in place, including adoption and termination dates.
For investors, 10b5-1 sales are generally less informative than open-market purchases. When you see a sale flagged as “pursuant to a 10b5-1 plan,” it often means the insider scheduled this months ago and it executed mechanically. That’s very different from a CEO waking up on Tuesday and deciding to buy $2 million of stock.
The Short-Swing Profit Rule (Section 16(b))
There’s one more guardrail worth knowing about. Section 16(b) of the Securities Exchange Act requires insiders to disgorge (return to the company) any profitsmade from buying and selling—or selling and buying—the company’s securities within a rolling six-month window.
This means insiders can’t flip the stock. If a CEO buys shares in January and sells at a profit in April, the company can claw back that profit. The calculation uses the most conservative matching method—pairing the lowest purchase price with the highest sale price to maximize the disgorgement amount.
The practical effect: when an insider buys on the open market, they’re locking up that capital for at least six months.This is a meaningful commitment, and it’s one reason open-market purchases carry more weight as signals.
What the Research Says
Decades of peer-reviewed academic research have consistently found that insider purchases predict positive stock returns. This isn’t speculation—it’s one of the most well-documented anomalies in finance.
Lakonishok & Lee (2001), in their landmark study published in the Review of Financial Studies, examined every NYSE, AMEX, and Nasdaq company from 1975 to 1995. They found that firms with heavy insider purchasing outperformed those with heavy insider selling by 7.8% over the following 12 months. Critically, they found that insider purchases are informative, while insider sales carry no significant predictive power.
Jeng, Metrick & Zeckhauser (2003), published in the Review of Economics and Statistics, estimated that insider purchases earn abnormal returns exceeding 6% annually. Insider sales, again, showed no significant abnormal returns.
H. Nejat Seyhunat the University of Michigan—arguably the foremost academic authority on insider trading—found that aggregate insider buying and selling ratios are highly predictive of future market returns, forecasting changes up to two years ahead. His research also revealed that chairmen of boards and officer-directors are more successful predictors than other insiders.
Famous Cases: When Insider Trading Crossed the Line
Understanding the illegal side helps clarify where the legal boundaries sit. Here are four landmark cases that shaped modern enforcement.
Stewart sold ~$230,000 in ImClone shares one day before the FDA publicly rejected the company’s cancer drug. Importantly, she was never convicted of insider trading itself—she was convicted of making false statements to federal agents and obstruction of justice.
The Galleon hedge fund case was the first to use wiretaps in a securities fraud investigation. Rajaratnam operated an extensive insider trading network spanning 8 companies and 25+ co-conspirators, generating over $25 million in illicit gains.
SAC Capital became the first major Wall Street institution in a generation to plead guilty to criminal insider trading, paying a record $1.8 billion penalty. Founder Steven Cohen was barred from managing outside money until 2018—though Cohen himself was never criminally charged.
A sitting U.S. congressman and board member of Innate Immunotherapeutics tipped his son about a failed drug trial while at a Congressional picnic at the White House. The tip allowed insiders to avoid over $768,000 in losses.
5 Myths About Insider Trading, Debunked
Myth #1: “All insider trading is illegal”
Wrong. Legal insider trading happens thousands of times per week across public companies. It’s only illegal when it involves trading on material nonpublic information in breach of a duty. The vast majority of insider transactions are routine, disclosed, and perfectly legal.
Myth #2: “Only executives can be prosecuted”
Anyone can be charged—employees, consultants, doctors, lawyers, friends of friends. The “misappropriation theory” means even someone with no company affiliation can face liability if they received a tip from someone who breached a duty of trust.
Myth #3: “Insider buys mean the stock will definitely go up”
Insiders aren’t clairvoyant. Research shows insider purchases predict higher returns on average, but individual trades can absolutely be wrong. The signal is statistical, not deterministic. That’s why cluster buying—multiple insiders buying simultaneously—is a much stronger signal than any single transaction.
Myth #4: “Insider selling means trouble”
Usually not. Insiders sell for dozens of reasons unrelated to their view of the stock. Research explicitly found that insider sales have no significant predictive ability for future returns. Context matters: selling a small percentage of holdings for diversification is very different from a CEO dumping their entire stake.
Myth #5: “It’s easy to prove insider trading”
It’s extremely difficult. Prosecutors must prove that the person possessed MNPI, that the information was material, that they were aware of it when they traded, and that a duty was breached. This is why many suspected cases never result in charges, and why enforcement relies on sophisticated tools like wiretaps and trading pattern analysis.
Why This Matters for Your Portfolio
Legal insider trading data is one of the few publicly available datasets where people with genuine informational advantages reveal their convictions with real money. Unlike analyst ratings (which are often conflicted) or social media hype (which is often noise), an insider buying stock means someone who knows the business intimately believes it’s undervalued enough to deploy their personal capital.
The research is clear: tracking insider purchases—especially open-market buys by senior executives—gives retail investors a meaningful informational edge. The key is knowing what to look for, filtering out the noise, and focusing on the transactions that actually carry signal.
Track Insider Trades in Real Time
MarketPeel monitors every Form 4 filing and surfaces the insider buys that matter—so you can follow the smart money without digging through EDGAR yourself.
Get Started with MarketPeel →- U.S. Securities and Exchange Commission, “Officers, Directors and 10% Shareholders.”
- Cornell Law Institute, “Insider Trading.”
- Dynamis LLP, “Understanding Insider Trading: Legal Framework & Enforcement.”
- SEC, “Insider Transactions and Forms 3, 4, and 5.”
- SEC, “SEC Adopts Amendments to Modernize Rule 10b5-1 Insider Trading Plans,” Press Release 2022-222, December 14, 2022.
- Greenberg Traurig LLP, “SEC Adopts Final Amendments to Rule 10b5-1 and New Disclosure Requirements,” January 2023.
- NASPP, “Section 16(b): The Short-Swing Profit Rule.”
- Jeng, L.A., Metrick, A. & Zeckhauser, R. (2003). “Estimating the Returns to Insider Trading.” The Review of Economics and Statistics, 85(2), 453–471.
- Lakonishok, J. & Lee, I. (2001). “Are Insider Trades Informative?” The Review of Financial Studies, 14(1), 79–111.
- Seyhun, H.N. Investment Intelligence from Insider Trading. MIT Press.
- SEC, “Martha Stewart and Peter Bacanovic,” Litigation Release No. 19794.
- SEC, “SEC Charges Billionaire Hedge Fund Manager Raj Rajaratnam,” Press Release 2009-221.
- SEC, “Steven A. Cohen Barred From Supervisory Hedge Fund Role,” Press Release 2016-3.
- U.S. Department of Justice, “Former Congressman Christopher Collins Sentenced for Insider Trading.”
- FINRA, “5 Surprising Facts About Insider Trading.”
- 2IQ Research, “Profiting From Insider Transactions: A Review of the Academic Research.”